Stoke Therapeutics (STOK) Return on Sales: 2022-2025
Historic Return on Sales for Stoke Therapeutics (STOK) over the last 3 years, with Sep 2025 value amounting to 0.20%.
- Stoke Therapeutics' Return on Sales rose 650.00% to 0.20% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.20%, marking a year-over-year increase of 650.00%. This contributed to the annual value of -2.43% for FY2024, which is 952.00% up from last year.
- Per Stoke Therapeutics' latest filing, its Return on Sales stood at 0.20% for Q3 2025, which was down 24.95% from 0.26% recorded in Q2 2025.
- Over the past 5 years, Stoke Therapeutics' Return on Sales peaked at 0.26% during Q1 2025, and registered a low of -8.48% during Q1 2024.
- Moreover, its 3-year median value for Return on Sales was -6.81% (2023), whereas its average is -4.79%.
- In the last 5 years, Stoke Therapeutics' Return on Sales slumped by 167bps in 2024 and then surged by 875bps in 2025.
- Quarterly analysis of 4 years shows Stoke Therapeutics' Return on Sales stood at -8.16% in 2022, then soared by 53bps to -7.63% in 2023, then spiked by 519bps to -2.44% in 2024, then spiked by 650bps to 0.20% in 2025.
- Its Return on Sales was 0.20% in Q3 2025, compared to 0.26% in Q2 2025 and 0.26% in Q1 2025.